Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Professor Kam Bhui, Professor of Psychiatry (Department of Psychiatry), is researching how to help young people who have suffered Adverse Childhood Experiences. Creative processes offer new perspectives, personalised options and choice.

Young child with tearful eyes

Adverse Childhood Experiences (ACEs) can refer to a range of experiences from verbal, sexual, or physical abuse; to neglect; substance misuse, or family mental illness. It can also include bullying, poverty, racism, traumatic losses, food shortages, harsh experiences in care, poor academic performance, and living in unsafe environments.

By the age of eight, 7 in 10 children report at least one such experience. These can have significant impacts on children’s lives, even reducing life expectancy by up to 20 years and causing social, emotional, and cognitive impairment, risky behaviours, disability, social exclusion, poor health. Three in four ACE-exposed adolescents develop mental health problems by the age of 18, including self-harm, suicide attempts, and post-traumatic stress disorders.

Read the full story on the University of Oxford website.

Similar stories

Oxford vaccine reaches one billion doses released

The University of Oxford’s and our partners AstraZeneca have today announced that one billion doses of the ChAdOx1 nCov-19 coronavirus vaccine have been released, to more than 170 countries, marking a key milestone as part of the University and AstraZeneca’s joint vision to make the available to the world, on a not-for-profit basis for the world during the pandemic, and in perpetuity for low- and middle-income countries.

Research programme tackling COVID-19 variants of concern receives funding boost

A gift from the Red Avenue Foundation will enable the expansion of a major research programme aimed at rapidly identifying and interrogating emerging COVID-19 variants.

Phase I trial begins of new vaccine against the Plague

Researchers at the University of Oxford today launched a Phase 1 trial to test a new vaccine against plague.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.